-
The digital transformation of the manufacturing industry is imminent, and the application space of "5G + pharmaceutical equipment" can be expected
Time of Update: 2022-08-19
In terms of specific applications in the industrial industry, 5G technology will bring significant gains to traditional manufacturing fields such as pharmaceutical equipment, including quality and efficiency enhancement, energy conservation and environmental protection, etc.
-
How can pharmaceutical equipment companies reduce costs?
Time of Update: 2022-08-19
Lean production management has become a trend (Source: Pharmaceutical Network) The author believes that in the face of the current fierce competition in the pharmaceutical machine market, although pharmaceutical machine companies can use price advantages to attract users in the short term, it is not a long-term development strategy, especially in recent years.
-
From three perspectives, institutions are optimistic about the performance of pharmaceutical equipment in the field of medicine
Time of Update: 2022-08-19
At the same time, pharmaceutical equipment belongs to the field of high-end manufacturing, and some high-end pharmaceutical equipment has also been encouraged and supported by national policies in recent years, encouraging pharmaceutical machine companies to speed up the pace of domestic substitution .
-
The outbreak of the biopharmaceutical industry is driving the pharmaceutical machine industry to usher in more market increments
Time of Update: 2022-08-19
The industry expects that, influenced by many policies that are favorable to the development of the biomedical economy, China's strategic scientific and technological strength in the biological field will continue to grow, which will strongly support the high-quality development of the bioeconomy .
-
The competitive environment of traditional Chinese medicine formula granules is increasingly fierce, and traditional Chinese medicine pharmaceutical companies are accelerating the layout
Time of Update: 2022-08-19
76%, of which, The specialty and traditional Chinese medicine formula granule business has achieved rapid growth; Shenwei Pharmaceutical's annual report shows that in 2021, the sales revenue of the traditional Chinese medicine formula granule business will be 693 million yuan, an increase of 24.
-
Under the centralized procurement, a large number of medical representatives are facing elimination!
Time of Update: 2022-08-19
[Pharmaceutical Network Market Analysis] Recently, the news that a maternal and child health care hospital has taken many measures to strengthen the management of medical representatives has made the industry of medical representatives once again become the focus of the industry .
-
This pharmaceutical stock has 9 daily limits in the past 14 trading days, with a cumulative increase of more than 45%
Time of Update: 2022-08-19
Tianlong Technology proposed that the remaining 38% of the shares should be traded at 900 million as agreed in the contract or 25 times the profit of the current year .
-
This pharmaceutical stock has increased by more than 12% in the closing price for 3 consecutive trading days.
Time of Update: 2022-08-19
[Pharmaceutical Network Pharmaceutical Stock Market] On August 17, Yan'an Bikang announced that the company's stock trading price increased for 3 consecutive trading days (August 12, 2022, August 15, 2022, and August 16, 2022).
-
Domestic pharmaceutical equipment is broken and the future market growth can be expected
Time of Update: 2022-08-19
[Pharmaceutical Network Market Analysis] The domestic pharmaceutical equipment industry, which is accelerating the pace of import substitution, is showing stronger development resilience .
[Pharmaceutical Network Market Analysis] The domestic pharmaceutical equipment industry, which is accelerating the pace of import substitution, is showing stronger development resilience .
-
Pharmaceutical ETF investment enthusiasm is high in the industry: CXO and other sub-tracks are still attractive
Time of Update: 2022-08-19
The main reason for the increase in performance is the sales of iHealth kit products Driven by growth; Vaccine head company Wantai Bio is expected to achieve a net profit of 2.
-
The launch of new domestic drugs is continuing to accelerate, and these types of drugs have become a hot track!
Time of Update: 2022-08-19
Industry analysts believe that on the whole, the launch of new domestic drugs will continue to accelerate, and the three major tracks will be favored by pharmaceutical companies, with an increasingly broad market development space .
-
Another drug of Kexing Pharmaceuticals, which is deeply involved in the antiviral field, received IND acceptance
Time of Update: 2022-08-19
With the introduction of two products, SHEN26, a small molecule oral drug against COVID-19, and human interferon α2b, into the clinic, Kexing Pharma has a more complete and rich pipeline of antiviral products .
-
Traditional testing cannot meet the high-speed production requirements of pharmaceutical companies?
Time of Update: 2022-08-19
The so-called machine vision technology is a non-contact, non-destructive automatic detection technology, which can meet the requirements of high efficiency and high precision in the inspection process of pharmaceutical companies' bottles, improve product quality, reduce costs, and avoid the occurrence of manual visual inspection.
-
Won a national award!
Time of Update: 2022-08-19
. AI Target Reconstruction Solution for Lung Nodules The patented technology is not limited to CT images, but can also be applied to high-dimensional image data such as MRI .
-
Midea takes the lead in medical treatment to build a full map from life to life
Time of Update: 2022-08-19
Its hardware equipment not only has a solid technical foundation and market foundation, but also based on The "Wanli Cloud" platform of imaging equipment is also at the forefront of the medical imaging big data cloud platform industry; Swisslog Medical, which is good at hospital logistics and pharmacy automation, can form a perfect "match" with the medical sector of Midea Building Technology Division.
-
Pharmaceutical machine companies are looking for new growth points, and diversified development has become the general trend!
Time of Update: 2022-08-19
Driven by the industrialization needs of local biopharmaceutical innovation companies and the CDMO industry with global competitiveness, it has been increasing investment in R&D in recent years, accelerating technological transformation and product structure diversification .
-
The deviation of the closing price of this pharmaceutical stock for 3 consecutive trading days has accumulated more than 20%
Time of Update: 2022-08-19
The 2021 annual report shows that as of December 31, 2021, the company's total operating income was 354 million yuan, a year-on-year increase of 14.
The 2021 annual report shows that as of December 31, 2021, the company's total operating income was 354 million yuan, a year-on-year increase of 14.
-
What happened to the pharmaceutical companies after the special centralized procurement of insulin was implemented?
Time of Update: 2022-08-19
[Pharmaceutical Network Market Analysis] After the selected varieties of insulin special centralized procurement with an average price drop of 48% are implemented, it is a boon for the majority of pa
-
The traditional Chinese medicine sector reappeared, and two stocks including Panlong Pharmaceutical Co., Ltd.
Time of Update: 2022-08-15
. Regarding the reasons for the change, the analysis believes that the company's main products Xingnaojing injection and Shenmai injection are listed in the sixth, seventh, eighth and ninth editions of the National Health Commission and the State Administration of Traditional Chinese Medicine.
-
The profit of Chinese herbal decoction pieces increased by 102%, and the market size is expected to be further expanded
Time of Update: 2022-08-15
The information-based system completes the transformation from a traditional decoction piece factory to a digital decoction piece factory, fundamentally solves the non-reproducibility of traditional Chinese medicine decoction pieces based on experience, realizes the transparency and traceability of the production process, and fully guarantees the stability of the quality of Chinese medicine decoction pieces , and at the same time improve production efficiency, achieve cost reduction and increase quality and efficiency .
